Heilongjiang Hengxin Pharmaceutical Co., Ltd. was established in April 2019. It is a pharmaceutical manufacturer mainly engaged in the production of nucleoside antiviral chemical raw materials with a registered capital of RMB 30 million. The main products are raw materials such as acyclovir, ganciclovir, ribavirin and their pharmaceutical intermediates. The company is located in Wanbaoshan Fine Chemical Park, Anda City, Suihua City, Heilongjiang Province. It is currently under construction and covers an area of ​​more than 100,000 square meters. The total investment of the project is RMB 330 million, and the construction period is 3 years. After completion, the project is expected to achieve an annual output value of RMB 550 million, a tax revenue of RMB 30 million, and employment for more than 200 people.